These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children. Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944 [TBL] [Abstract][Full Text] [Related]
4. [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease]. Fujiwara H; Mise N; Ishimoto Y; Kotera N; Tanaka M; Tanaka S; Kurita N; Fujii A; Yamaguchi Y; Sugimoto T Nihon Jinzo Gakkai Shi; 2011; 53(2):189-94. PubMed ID: 21516705 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase. Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409 [TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma. Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620 [TBL] [Abstract][Full Text] [Related]
7. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels. Kazama JJ; Yamamoto T; Oya H; Yamamoto S; Sato Y; Sakurada J; Honda T; Endoh H; Narita I J Bone Miner Res; 2010 Jun; 25(6):1455-9. PubMed ID: 20200933 [TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia Associated with the Ectopic Expression of 25-hydroxyvitamin D3-1α-hydroxylase in Diffuse Large B-cell Lymphoma. Ogawa M; Morikawa M; Kobatake M; Murakami T; Yamamoto Y; Watanabe R; Yamada K; Nishiyama K; Yasutomo Y; Hara K Intern Med; 2022; 61(16):2489-2495. PubMed ID: 35965075 [TBL] [Abstract][Full Text] [Related]
9. [Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6]. Nakamura H; Nakaseko C; Ishii A; Kogure K; Kawano E; Hashimoto S; Nishimura M; Matsuura Y; Oh H; Yoshida S Rinsho Ketsueki; 1993 Feb; 34(2):212-7. PubMed ID: 8492420 [TBL] [Abstract][Full Text] [Related]
10. [Multicentric Castleman's disease with multiple hepatic mass lesions mimicking malignant liver tumors]. Ueki T; Nasuno M; Kaiume H; Hiroshima Y; Sumi M; Watanabe M; Inoue D; Masaki Y; Sato Y; Kojima M; Kobayashi H Rinsho Ketsueki; 2017; 58(6):630-636. PubMed ID: 28679994 [TBL] [Abstract][Full Text] [Related]
11. The other side of vitamin D therapy: a case series of acute kidney injury due to malpractice-related vitamin D intoxication . Wani M; Wani I; Banday K; Ashraf M Clin Nephrol; 2016 Nov; 86 (2016)(11):236-241. PubMed ID: 27719737 [TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual. Haridas K; Holick MF; Burmeister LA Nutrition; 2020 Jun; 74():110754. PubMed ID: 32222584 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease. Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767 [TBL] [Abstract][Full Text] [Related]
15. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis. Gates S; Shary J; Turner RT; Wallach S; Bell NH J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540 [TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Falk S; Kratzsch J; Paschke R; Koch CA Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303 [TBL] [Abstract][Full Text] [Related]
17. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait. Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117 [TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Motoyama K; Inaba M; Emoto M; Morii H; Nishizawa Y Intern Med; 2002 Jun; 41(6):449-52. PubMed ID: 12135177 [TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia due to hypervitaminosis D: report of seven patients. Joshi R J Trop Pediatr; 2009 Dec; 55(6):396-8. PubMed ID: 19339514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]